A study of price reduction sustainability in national volume-based drug procurement

Corresponding author: Luo Li, liluo@fudan.edu.cn

DOI: 10.12201/bmr.202305.00008

•  

  Abstract: Objectives: To analyze the continuous effect of the price reduction of the national drug procurement policy and explore measures for the stable operation of centralized drug prices. Methods: The procurement data of the first five batches of centralized drugs in medical institutions nationwide in the comprehensive service platform for centralized drug procurement were used to describe the price changes of centralized procurement drugs by using the Laspeyres price index and the Fisher price index. Results: The price reduction of selected drugs in centralized procurement reached 50%-85%, and the price reduction of unselected drugs with the same generic name reached 10%-40%, and the price reduction effect was long-lasting, and the price of some drugs increased after selection. Conclusion: The national centralized procurement policy can not only sustainably and significantly reduce the price of selected drugs, but also reduce the price of unselected drugs with the same generic name. It is recommended to build a monitoring and early warning system for the operation of centralized drug prices to strengthen drug price monitoring and expand the scope of centralized drug procurement.

  Key words: National centralized drug procurement policy; Price index; Price analysis

  Submit time: 10 May 2023

  Copyright: The copyright holder for this preprint is the author/funder, who has granted biomedRxiv a license to display the preprint in perpetuity.
• html

• 图表

• Sun Yan, Zhu Zheng, Yang Li. Influencing factors analysis on price reduction in national volume-based drug procurement.. 2022. doi: 10.12201/bmr.202203.00008

  SUN Wenjun, ZHAO Ziyin, CHENG Zheyu, LI Huining, ZHU He. Impact of the national centralized drug procurement policy on drug prices and utilization: a systematic review. 2023. doi: 10.12201/bmr.202303.00033

  WangBiao, Zhang Tiantian, Tang Xiaoyu, Jia Yun, Luo Li. Research on the price difference and regional distribution of selected drugs in Chinas centralized procurement. 2023. doi: 10.12201/bmr.202306.00008

  LIU MINGZHU, LU YUN. Research on the Implementation Effect of Expiration of National Pharmaceutical Centralized Volume-based Procurement Based on Intermittent Time Series: A Case Study of Hebei Province. 2023. doi: 10.12201/bmr.202306.00007

  LI Zhao, Zhao Ke, Zhou Lulin, Chen Sheng. Research on the Comparison and Development Countermeasures of Pharmaceutical Group Purchasing Modes from the Perspective of the Normalization of National Centralized Procurement. 2021. doi: 10.12201/bmr.202109.00037

  Tang Yuqing, Li Yinming, Chen Xizhuo, Xue Tianqin, Chen Hao. Analysis of the Execution of Centralized Drug Procurement Policy Based on Policy Implementation System Model. 2023. doi: 10.12201/bmr.202310.00002

  HAN Meng, WANG Shi-jia, HU Hao-yu, ZHAO Yan-jiao, CHEN Yong-fa. Comparative Study on Grouping Rules in Centralized Volume-based Procurement of Chinese Patent Medicine. 2023. doi: 10.12201/bmr.202312.00008

  songjia, fanchengxin, wangwanchen, aixufeng, liuxinlu, licuiyu, zhangyujie, liqiusha, wanganqi, fengzhiqiang, yinwenqiang, madongping. Study on Chinas centralized quantity purchasing policy for drugs from the perspective of stakeholders - a textual analysis based on policy tools. 2022. doi: 10.12201/bmr.202203.00006

  ZENGXUHENG, ZHENGJI, LVJUN, NINGYULING, LIXIAOHONG. SWOT analysis on volume-based procurement of high-value medical consumables: A case of Shanghai. 2020. doi: 10.12201/bmr.202010.00841

  wangennan, zhuminglai. Evolutionary Game Research on Price Negotiation of Patent Medicine Medical Insurance in China. 2023. doi: 10.12201/bmr.202303.00032

• ID	Submit time	Number	Download
  1	2023-03-02	bmr.202305.00008V1	Download

• Public  Anonymous  To author only Submit Comments